StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)

Close on Nov 17, 2026Market cap $50.42MP/E –Yield –

Tonix Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tonix Pharmaceuticals's price to book ratio was 0.3× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.0× to 145.1×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.4
2025Dec 31, 20250.7×−0.0
2024Dec 31, 20240.7×−1.2
2023Dec 29, 20231.9×−16.3
2022Dec 30, 202218.2×−126.9
2021Dec 31, 2021145.1×−162.1
2020Dec 31, 2020307.2×+269.2
2019Dec 31, 201938.0×−304.0
2018Dec 31, 2018342.0×–

More Tonix Pharmaceuticals figures

See a number that looks wrong?